The two most common somatic mutations in NSCLC, particularly in LUAD, are an in-frame deletion in exon 19 and the L858R point mutation in exon 21, which together account for about 85% of all EGFR mutations. This evidence concerns the gene EGFR and non-small cell lung carcinoma.